triazoles has been researched along with Bacteremia in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Krishnan, T; Rishi, P | 1 |
Bayer, A; French, SW; Gebremariam, T; Ibrahim, AS; Lee, H; Luo, G; Spellberg, B; Xiong, YQ | 1 |
Akkapeddi, P; Haldar, J; Manjunath, GB; Yarlagadda, V | 1 |
Frauenfelder, T; Gerber, B; Köppel, J; Manz, MG; Nair, G; Nguyen-Kim, TD; Paul, M; Schanz, U | 1 |
Fernandes, P; Pereira, D | 1 |
Csóka, B; Deitch, EA; Haskó, G; Ledent, C; Lu, Q; Németh, ZH; Pacher, P; Spolarics, Z; Wilmanski, J; Xu, D | 1 |
Gottfredsson, M; Steingrímsdóttir, H | 1 |
Chang, CL; Kim, MN; Kim, SH; Lee, HS; Lee, JS; Lee, K; Lee, WG; Ryang, DW; Shin, BM; Shin, JH; Shin, MG; Suh, SP; Uh, Y | 1 |
Bar-Natan, MF; Garrison, RN; Spain, DA; Wilson, MA | 1 |
Darius, H; Heuer, HO; Lohmann, HF; Meyer, J; Schierenberg, M; Treese, N | 1 |
10 other study(ies) available for triazoles and Bacteremia
Article | Year |
---|---|
Management of a case of Candida endogenous endophthalmitis in a neonate.
Topics: Anti-Bacterial Agents; Bacteremia; Burkholderia cepacia; Candida tropicalis; Candidemia; Ceftazidime; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Infections, Fungal; Humans; Infant, Newborn; Intravitreal Injections; Pyrimidines; Triazoles; Vancomycin; Voriconazole | 2014 |
Combination therapy with iron chelation and vancomycin in treating murine staphylococcemia.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Load; Benzoates; Chelating Agents; Deferasirox; Disease Models, Animal; Drug Therapy, Combination; Iron; Kidney; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability; Severity of Illness Index; Spleen; Staphylococcal Infections; Treatment Outcome; Triazoles; Vancomycin | 2014 |
Membrane active vancomycin analogues: a strategy to combat bacterial resistance.
Topics: Animals; Bacteremia; Cell Membrane Permeability; Drug Resistance, Bacterial; Enterococcus; Female; HeLa Cells; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Neutropenia; Quaternary Ammonium Compounds; Staphylococcal Infections; Staphylococcus; Structure-Activity Relationship; Triazoles; Vancomycin | 2014 |
Efficacy of anti-fungal but not anti-bacterial prophylaxis in intensive primary AML therapy: a real-world, retrospective comparative single-centre study.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Bacteremia; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Mycoses; Retrospective Studies; Survival Rate; Triazoles | 2014 |
Synthesis and antibacterial activity of novel 4-aryl-[1,2,3]-triazole containing macrolides.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Macrolides; Mice; Microbial Sensitivity Tests; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles | 2011 |
Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis.
Topics: Adenosine A2 Receptor Antagonists; Animals; Apoptosis; Bacteremia; Biomarkers; Cytokines; Gene Expression Profiling; Male; Mice; Mice, Knockout; Oligonucleotide Array Sequence Analysis; Receptor, Adenosine A2A; Spleen; Survival Rate; Triazines; Triazoles | 2006 |
Disseminated invasive aspergillosis in a patient with acute leukaemia.
Topics: Acute Kidney Injury; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bacteremia; Caspofungin; Chlamydophila Infections; Chlamydophila pneumoniae; Doxorubicin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Liposomes; Lung Diseases, Fungal; Medical Futility; Methotrexate; Middle Aged; Neuroaspergillosis; Peptides, Cyclic; Pneumonia, Bacterial; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Streptococcal Infections; Triazoles; Vincristine; Voriconazole | 2006 |
Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea.
Topics: Antifungal Agents; Azoles; Bacteremia; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole | 2007 |
Platelet-activating factor and sepsis-induced small intestinal microvascular hypoperfusion.
Topics: Animals; Azepines; Bacteremia; Escherichia coli Infections; Intestine, Small; Male; Microcirculation; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Triazoles; Vasoconstriction | 1995 |
Platelet-activating factor type activity in plasma from patients with septicemia and other diseases.
Topics: Adult; Animals; Azepines; Bacteremia; Blood Platelets; C-Reactive Protein; Female; Humans; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Purpura, Thrombocytopenic; Rabbits; Reference Values; Triazoles | 1991 |